Anebulo Pharmaceuticals, Inc. (ANEB)

NASDAQ: ANEB · Real-Time Price · USD

2.330

+0.020 (0.87%)

Oct 6, 2025, 4:00 PM EDT - Market closed

Anebulo Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Oct '25 Oct 6, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020
Market Capitalization	96	59	71	60	121	159	Upgrade
Market Cap Growth	77.47%	-16.43%	17.53%	-50.38%	-23.75%	-	Upgrade
Enterprise Value	84	46	66	46	105	159	Upgrade
Last Close Price	2.33	1.44	2.73	2.35	5.20	6.82	Upgrade
PB Ratio	8.21	5.08	18.57	5.68	8.06	7.44	Upgrade
P/TBV Ratio	8.21	5.08	18.57	5.68	8.06	7.44	Upgrade
Quick Ratio	23.99	23.99	11.87	10.52	28.39	82.71	Upgrade
Current Ratio	24.53	24.53	13.46	10.92	30.40	89.61	Upgrade
Return on Equity (ROE)	-109.69%	-109.69%	-113.80%	-91.42%	-37.42%	-249.85%	Upgrade
Return on Assets (ROA)	-71.09%	-71.09%	-65.97%	-54.05%	-22.93%	-18.30%	Upgrade
Return on Capital (ROIC)	-74.52%	-74.52%	-72.06%	-57.38%	-23.41%	-18.50%	Upgrade
Earnings Yield	-8.86%	-14.34%	-11.58%	-19.48%	-5.62%	-19.00%	Upgrade
Buyback Yield / Dilution	-30.97%	-30.97%	-2.98%	-7.41%	-71.49%	-13.44%	Upgrade

Updated Sep 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q